1. Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.
- Author
-
Fujita S, Shimojo N, Terasaki F, Otsuka K, Hosotani N, Kohda Y, Tanaka T, Nishioka T, Yoshida T, Hiroe M, Kitaura Y, Ishizaka N, and Imanaka-Yoshida K
- Subjects
- Animals, Anti-Inflammatory Agents administration & dosage, Atrial Natriuretic Factor administration & dosage, Cardiomegaly metabolism, Cardiomegaly pathology, Cardiomegaly prevention & control, Cells, Cultured, Disease Models, Animal, Fibrillar Collagens metabolism, Fibroblasts drug effects, Fibroblasts metabolism, Fibrosis, Heart Diseases chemically induced, Heart Diseases metabolism, Heart Diseases pathology, Heart Diseases physiopathology, Inflammation chemically induced, Inflammation metabolism, Inflammation pathology, Inflammation physiopathology, Inflammation Mediators metabolism, Infusions, Intravenous, Macrophages drug effects, Macrophages metabolism, Male, Mitral Valve drug effects, Mitral Valve physiopathology, Myocardial Contraction drug effects, Myocardium pathology, Rats, Rats, Inbred WKY, Stroke Volume drug effects, Time Factors, Ventricular Function, Left drug effects, Angiotensin II, Anti-Inflammatory Agents pharmacology, Atrial Natriuretic Factor pharmacology, Endothelin-1 metabolism, Heart Diseases prevention & control, Inflammation prevention & control, Myocardium metabolism, Receptor, Endothelin A metabolism, Signal Transduction drug effects, Ventricular Remodeling drug effects
- Abstract
We aimed to investigate whether atrial natriuretic peptide (ANP) attenuates angiotensin II (Ang II)-induced myocardial remodeling and to clarify the possible molecular mechanisms involved. Thirty-five 8-week-old male Wistar-Kyoto rats were divided into control, Ang II, Ang II + ANP, and ANP groups. The Ang II and Ang II + ANP rats received 1 μg/kg/min Ang II for 14 days. The Ang II + ANP and ANP rats also received 0.1 μg/kg/min ANP intravenously. The Ang II and Ang II + ANP rats showed comparable blood pressure. Left ventricular fractional shortening and ejection fraction were lower in the Ang II rats than in controls; these indices were higher (P < 0.001) in the Ang II + ANP rats than in the Ang II rats. In the Ang II rats, the peak velocity of mitral early inflow and its ratio to atrial contraction-related peak flow velocity were lower, and the deceleration time of mitral early inflow was significantly prolonged; these changes were decreased by ANP. Percent fibrosis was higher (P < 0.001) and average myocyte diameters greater (P < 0.01) in the Ang II rats than in controls. ANP decreased both myocardial fibrosis (P < 0.01) and myocyte hypertrophy (P < 0.01). Macrophage infiltration, expression of mRNA levels of collagen types I and III, monocyte chemotactic protein-1, and a profibrotic/proinflammatory molecule, tenascin-C (TN-C) were increased in the Ang II rats; ANP significantly decreased these changes. In vitro, Ang II increased expression of TN-C and endothelin-1 (ET-1) in cardiac fibroblasts, which were reduced by ANP. ET-1 upregulated TN-C expression via endothelin type A receptor. These results suggest that ANP may protect the heart from Ang II-induced remodeling by attenuating inflammation, at least partly through endothelin 1/endothelin receptor A cascade.
- Published
- 2013
- Full Text
- View/download PDF